Larry L. Trittschuh sells 11,526 shares of HealthEquity, Inc. (NASDAQ:HQY)


HealthEquity, Inc. (NASDAQ: HQY – Get a rating) Executive Vice President Larry L. Trittschuh sold 11,526 shares of the company in a trade dated Thursday, Oct. 13. The stock was sold at an average price of $70.00, for a total transaction of $806,820.00. Following the sale, the executive vice president now directly owns 27,961 shares of the company, valued at approximately $1,957,270. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, available at this link.

HealthEquity Trading up 1.0%

HQY traded $0.72 during Monday’s trading, hitting $71.75. 21,252 shares of the company were traded, against an average volume of 757,915. HealthEquity, Inc. has a 1-year low of $36.81 and a 1-year high of $74.04. The stock has a 50-day moving average price of $66.42 and a 200-day moving average price of $64.06. The company has a market capitalization of $6.07 billion, a P/E ratio of -95.99, a price-to-earnings growth ratio of 3.85 and a beta of 0.83.

HealthEquity (NASDAQ:HQY – Get a rating) last released its quarterly earnings data on Tuesday, September 6. The company reported earnings per share (EPS) of $0.33 for the quarter, hitting the consensus estimate of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. In the same quarter of the previous year, the company had earned earnings per share of $0.21. Analysts expect HealthEquity, Inc. to post earnings per share of 0.69 for the current fiscal year.

A Wall Street analyst gives his opinion

HQY has been the subject of a number of research analyst reports. KeyCorp launched coverage on HealthEquity shares in a Thursday, September 15, report. They set an “overweight” rating and a price target of $85.00 on the stock. Goldman Sachs Group kicked off HealthEquity stock coverage in a Tuesday, July 12 research report. They set a rating of “sell” and a target price of $59.00 for the business. Raymond James raised his price target on HealthEquity shares from $70.00 to $75.00 and gave the stock an “outperform” rating in a Monday, September 12 research report. Deutsche Bank Aktiengesellschaft raised its price target on HealthEquity shares from $67.00 to $68.00 and gave the stock a “buy” rating in a Thursday, September 8 research report. To finish, launched coverage on HealthEquity stocks in a Wednesday, Oct. 12 research report. They set a “sell” rating for the company. Two analysts rated the stock with a sell rating, one gave the company a hold rating and eleven gave the company a buy rating. According to MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $75.36.

Institutional investors weigh in on HealthEquity

Several institutional investors have recently bought and sold shares of HQY. Private Trust Co. NA bought a new position in shares of HealthEquity in the second quarter worth $28,000. Assetmark Inc. increased its equity stake in HealthEquity by 387.1% in the second quarter. Assetmark Inc. now owns 755 shares of the company valued at $46,000 after purchasing an additional 600 shares during the period. Signaturefd LLC increased its stake in shares of HealthEquity by 44.3% in the first quarter. Signaturefd LLC now owns 954 shares of the company valued at $64,000 after purchasing an additional 293 shares during the period. Clearstead Advisors LLC acquired a new stake in HealthEquity in the first quarter valued at $65,000. Finally, Eagle Bay Advisors LLC increased its stake in HealthEquity by 137.8% in the second quarter. Eagle Bay Advisors LLC now owns 1,108 shares of the company valued at $68,000 after acquiring 642 additional shares in the last quarter. 99.43% of the shares are currently held by hedge funds and other institutional investors.

About HealthEquity

(Get a rating)

HealthEquity, Inc provides technology service platforms to consumers and employers in the United States. The Company offers cloud-based platforms that allow individuals to make healthcare savings and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefits and clinical information, earn wellness incentives, increase savings, and make investment choices; and health savings accounts.

Further reading

Insider buying and selling by quarter for HealthEquity (NASDAQ:HQY)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider HealthEquity, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes viral…and HealthEquity wasn’t on the list.

Although HealthEquity currently has a “moderate buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here


About Author

Comments are closed.